C4 Therapeutics, Inc. (CCCC) Earnings
|
Expand Research on CCCC
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +5.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26  |
Q126 | N/A | -$0.29 | N/A | N/A | $4.44M | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/24/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/23/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/20/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/19/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.44 | -$0.41 | -$0.03 | $11.23M | $6.13M | N/A |  | | Details | |
| 11/3/25 |
Q325 | N/A | -$0.41 | N/A | N/A | $6.13M | N/A | N/A | N/A |
